Related Experiment Video
Updated: May 21, 2026

08:25
Mass Cytometry Analysis of Systemic and Local Immune Responses in Hepatocellular Carcinoma
Published on: April 25, 2025
Multisystem Langerhans cell histiocytosis with liver dysfunction as the first presentation: A case report
Dian-Gang Liu1, Yu-Xian Zhang, Fei Li
1Department of General Surgery, Xuanwu Hospital, Capital Medical University, Beijing 100053, P.R. China.
Oncology Letters
|June 29, 2012
Summary
Langerhans cell histiocytosis (LCH) is a rare multisystem disease. This case highlights diagnostic challenges due to atypical organ involvement and varied presentation, aiding LCH understanding and treatment.
Area of Science:
- Histiocytosis and related disorders
- Oncology
- Pathology
Background:
- Langerhans cell histiocytosis (LCH) is a rare clonal proliferative disease of Langerhans cells with unknown etiology.
- LCH diagnosis is challenging due to diverse clinical presentations and multi-organ involvement, ranging from isolated to systemic disease.
Purpose of the Study:
- To report a complex case of multisystem Langerhans cell histiocytosis (LCH) with initial liver dysfunction presentation.
- To highlight diagnostic difficulties in LCH due to atypical organ involvement and varied clinical manifestations.
Main Methods:
- Case report of a 35-year-old male diagnosed with multisystem LCH.
- Diagnostic procedures included skull and liver biopsies.
- Treatment involved chemotherapy, leading to partial remission.
Main Results:
- The patient presented with liver dysfunction, later diagnosed with LCH involving bones, lungs, spleen, liver, and bile ducts.
- Skull biopsy confirmed Langerhans cell infiltration, but liver biopsy showed sclerosing cholangitis without LCH cells.
- Atypical organ involvement and presentation led to diagnostic delays.
Conclusions:
- This case underscores the diagnostic complexities of LCH, particularly when presenting atypically.
- Findings may improve understanding of LCH pathophysiology, diagnosis, and treatment strategies.
- Early and accurate diagnosis is crucial for effective management of LCH.
Related Concept Videos
Cirrhosis I: Introduction
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...